Revive the whole experience NOW
DAY 2
Friday 6 November 2020
Liverpool Meeting
Key drug interaction issues from EASL Guidelines 2020
Fiona Marra
Role of the pharmacist in DAA prescribing and HCV elimination.
Alison Boyle
Managing HIV/HCV/TB coinfection: the hard way for cure.
Ahmed Cordie
Ismail Anwar
Ayat Abdallah
Fathia Hamed
Yasmin Gaber
Breakthrough in biological therapy
COVID Recap
Covid Summary
Mohamed El Badry
Covid Summary
Mohamed El Badry
Role of lung ultrasound during COVID-19 pandemic
Samy Zaky
Mansoura -NZIR study for treatment of COVID-19: a single-center experience
Mahmoud El Bendary
Mansoura -NZIR study for treatment of COVID-19: a single-center experience
Mahmoud El Bendary
.
Plenary Session III
Hepatorenal syndrome
Imam Waked
Fungal dysbiosis and gastrointestinal disorders
Maysaa Abdallah
Future therapies for HBV cure
Marc Bourliere
Future therapies for HBV cure
Marc Bourliere
Dual release proton pump inhibitors; are they different?
Ahmed Zaid
Dual release proton pump inhibitors; are they different?
Ahmed Zaid
Interactive Sessions
Annoying problems in cirrhotic patients (intractable itching, muscle cramps)
Hypersplenism and its sequelae: multidisciplinary approach
HCC in Liver transplantation, what’s beyond the Milan criteria
Chronic fatigue syndrome: a truth or myth and how to approach?
Travel medicine
Unexplained prolonged fever: Algorithmic approach
Industrial Spot
Sanofi
Neuro endocrinal tumors: Case presentation
Sherif Megawer
Effect of bariatric surgery on GERD
Mohamed Magdy
Communicable diseases: pre- and post-exposure prophylaxis.
Fatma Ali El Din
Communicable diseases: pre- and post-exposure prophylaxis.
Fatma Ali El Din
Cirrhotic Cardiomaypathy
Sam Lee
Cirrhotic Cardiomaypathy
Sam Lee